Australia's largest stock trading and investment forum Australia's #1 stock forum

RAP

0.00%

20.5¢ resapp health limited

This is more recent....

First 1610 Last

Share
Profile

Follow
AlCp

26,752 Posts.

1732

04/12/20

08:42

Post #: 49336412
Share

Originally posted by Dhm ↑

Brisbane, Australia, 24 April 2018 — ResApp Health Limited (ASX:RAP), a leading digital health company developing smartphone applications for the diagnosis and management of respiratory disease, is pleased to announce that it has signed a letter of intent (LOI) with a German private hospital network to run a pilot project to test the applicability and integration of ResAppDx, ResApp’s smartphone application for diagnosing acute respiratory disease, within a German hospital structure.

The partners will work together to design and run a six-month pilot project at one or more of the network’s hospitals in Germany at no-cost to ResApp. The pilot project must be started by November 1, 2018 and ResApp will not receive revenue from the pilot. At the completion of the project ResApp has agreed to grant the network an exclusive, no-cost license to use ResAppDx in their hospitals in Germany for six months and a non-exclusive, no-cost license for an additional six months. Successful completion of the pilot may lead to the network negotiating a commercial licensing agreement for use in their hospitals. Under the LOI neither party has taken on any obligations regarding ResAppDx following the pilot project and subsequent no-cost license periods.

“We are excited to be working with a leading German hospital network. This gives us a unique opportunity to work closely with European clinicians and hospital executives, providing us with invaluable insight into European clinical practice and hospital operations,” said Tony Keating, CEO and Managing Director of ResApp Health. “We expect this project to significantly accelerate the commercialisation of ResAppDx in Europe.”

Expand

This is more recent.
https://www.resapphealth.com.au/wp-content/uploads/2020/06/2070168.pdf

RAP Price at posting: 8.9¢ Sentiment: Buy Disclosure: Held
6 Upvote

0 Great analysis

Reply

Top Stories

LLC

ACCC raises competition concerns about acquisition of Lendlease projects

LAT

Latitude 66 Shares Surge 8900% on Promising Exploration Update

ALK

Alkane Resources hit 57.2Kozpa gold production through FY24 – and eyeing 70Ktpa in FY26

XRG

XReality Group wins $800K contract from Aus Government for military and police VR training tech

AS2

Askari sets exploration target of up to 323K ounces Au at Burracoppin